Fulgent Genetics, Inc. Common Stock
$21.63
$0.35 (+1.64%)
$21.20Day Range$21.81
Key Statistics
Market Cap
$595.16M
Shares Outstanding
27.5M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Sep 29, 2016
Round Lot
100
Locale
US
Trading Data
Day Open
$21.31
Day High
$21.81
Day Low
$21.20
Volume
328.3K
VWAP
$21.56
Prev Close
$21.28
Transactions
--
Acc. Volume
--
About Fulgent Genetics, Inc. Common Stock
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
SERVICES-MEDICAL LABORATORIESSIC 80711,315 employees4399 SANTA ANITA AVE, EL MONTE, CA, 91731626-350-0537IPO Sep 29, 2016US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001674930
- Composite FIGI
- BBG00DR7LTG2
- Share Class FIGI
- BBG00DW0QQM5
- Ticker Root
- FLGT
- SIC Code
- 8071
About Fulgent Genetics, Inc. Common Stock (FLGT) Stock
Fulgent Genetics, Inc. Common Stock (FLGT) closed the 2026-09-16 session at $21.63, up 1.64% versus the previous close (+0.35). The stock opened at $21.31 and traded between $21.20 and $21.81 during that session. Session trading volume was 328K shares. The volume-weighted average price (VWAP) is $21.56.
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.
Fulgent Genetics, Inc. Common Stock has a market capitalization of $595.2 million. The company operates in the SERVICES-MEDICAL LABORATORIES industry classification. FLGT is listed on the XNAS exchange. The company employs approximately 1,315 people. Fulgent Genetics, Inc. Common Stock is headquartered in EL MONTE, CA. The recorded listing date is 2016-09-29.
On this page you can find market FLGT stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SERVICES-MEDICAL LABORATORIES sector.